These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6138150)

  • 1. Effectiveness of antiarrhythmic agents in preventing death in ventricular fibrillation induced by isoprenaline in desoxycorticosterone-pretreated rats.
    Green M; Guideri G; Lehr D
    Cardiovasc Res; 1983 Sep; 17(9):562-7. PubMed ID: 6138150
    [No Abstract]   [Full Text] [Related]  

  • 2. Death in ventricular fibrillation induced by isoproterenol in DOCA-salt pretreated rats preceded by changes in myocardial electrolytes.
    Guideri G
    Life Sci; 1983 Oct; 33(14):1353-62. PubMed ID: 6621246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical aspects of arrhythmogenesis and ventricular fibrillation.
    Opie LH; Nathan D; Lubbe WF
    Am J Cardiol; 1979 Jan; 43(1):131-48. PubMed ID: 31786
    [No Abstract]   [Full Text] [Related]  

  • 4. Method for the production of severe ventricular dysrhythmias in small laboratory animals.
    Guideri G; Barletta M; Chau R; Green M; Lehr D
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():661-79. PubMed ID: 1209009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs.
    Podzuweit T; Lubbe WF; Opie LH
    Lancet; 1976 Feb; 1(7955):341-2. PubMed ID: 54744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular fibrillation threshold and myocardial cyclic AMP production in rats sensitive or resistant to isoproterenol.
    Joseph X; Jordan AW; Balazs T
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):239-49. PubMed ID: 6330819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Improvement of ventricular fibrillation by decreasing isoprenaline accumulation in the myocardium].
    Sono K; Magaribuchi T; Kurahashi K; Fujiwara M
    Kokyu To Junkan; 1984 Nov; 32(11):1119-22. PubMed ID: 6522855
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of ethinyl estradiol on isoproterenol-induced death in ventricular fibrillation in DOCA-salt pretreated male and female rats.
    Healy C; Milmore JE; Guideri G
    Life Sci; 1991; 48(20):1931-6. PubMed ID: 2023523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-arrhythmic action of a carbon tetrafluoride emulsion].
    Afonin NI; Alabovskiĭ VV; Doronina NN
    Biull Eksp Biol Med; 1982 Jul; 94(7):60-1. PubMed ID: 7126831
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sudden heart death in ventricular heart rhythm disorders: possibilities and limits of long-term therapy].
    Lüderitz B; Manz M; Steinbeck G
    Internist (Berl); 1984 Jul; 25(7):415-20. PubMed ID: 6147323
    [No Abstract]   [Full Text] [Related]  

  • 11. A cardiac antiarrhythmic screening test using the isolated ischaemic perfused rat heart preparation.
    Lee AY; Zhan CY; Mok CP; Wong TM
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):217-22. PubMed ID: 4062438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
    Candinas R; Bauersfeld U
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced incidence of isoproterenol-induced ventricular fibrillation in the magnesium-deficient rat.
    Guideri G; Lehr D; Horowitz S
    J Am Coll Nutr; 1985; 4(2):139-55. PubMed ID: 4019937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of alpha- and beta-adrenergic activation in ventricular fibrillation death of corticoid-pretreated rats.
    Green M; Guideri G; Lehr D
    J Pharm Sci; 1980 Apr; 69(4):441-4. PubMed ID: 6103072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antiarrhythmic agents on isoproterenol-induced ventricular fibrillation in heavy rats: a possible model of sudden cardiac death.
    Johnson GL; Ehrreich SJ; el-Hage AN; Balazs T
    Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):351-64. PubMed ID: 3704313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various aspects of the anti-arrhythmia action of trimecaine and its effect on hemodynamics].
    Kostin IaV; Oleĭnikov VE; Sernov LN; Tatarchenko IP; Gendenshteĭn EI
    Farmakol Toksikol; 1984; 47(1):47-50. PubMed ID: 6200357
    [No Abstract]   [Full Text] [Related]  

  • 17. Sotalol: the mechanism of its antiarrhythmic-defibrillating effect.
    Manoach M; Tribulova N
    Cardiovasc Drug Rev; 2001; 19(2):172-82. PubMed ID: 11484069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of isoprenaline as an antiarrhythmic agent after valve replacement surgery.
    Gunning JF; Shanahan MX; Windsor HM
    Br Heart J; 1969 Jan; 31(1):83-6. PubMed ID: 5774039
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of antiarrhythmic drugs on the extraneuronal accumulation of isoprenaline in perfused rat hearts.
    Sono K; Akimoto Y; Kurahashi K; Fujiwara M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):145-8. PubMed ID: 2878375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The anti-arrhythmia activity of quinazopyrine].
    Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
    Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.